Published in Malar J on February 28, 2011
The parasite clearance curve. Malar J (2011) 4.30
A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One (2011) 1.47
Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med (2015) 1.24
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization. Antimicrob Agents Chemother (2013) 1.21
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers. J Infect Dis (2013) 1.15
Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR. Antimicrob Agents Chemother (2015) 0.99
Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection. PLoS One (2013) 0.95
Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia. J Infect Dis (2016) 0.94
Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. Malar J (2012) 0.89
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development. Antimicrob Agents Chemother (2016) 0.85
Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production. PLoS Pathog (2016) 0.80
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malar J (2016) 0.79
Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study. Sci Rep (2017) 0.78
Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects. Br J Clin Pharmacol (2016) 0.78
Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration. J Infect Dis (2016) 0.78
A High Malaria Prevalence Identified by PCR among Patients with Acute Undifferentiated Fever in India. PLoS One (2016) 0.77
Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers. J Antimicrob Chemother (2016) 0.77
Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection. Infect Immun (2016) 0.77
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection. Cell Rep (2016) 0.76
Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite. Infect Immun (2016) 0.76
Plasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential. PLoS Negl Trop Dis (2016) 0.75
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. Lancet Infect Dis (2017) 0.75
Dichotomous miR expression and immune responses following primary blood-stage malaria. JCI Insight (2017) 0.75
Human malaria parasites in continuous culture. Science (1976) 59.70
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. Am J Trop Med Hyg (2005) 2.77
Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis (2009) 2.64
Current status of malaria and potential for control. Clin Microbiol Rev (2001) 1.92
A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. Mol Biochem Parasitol (2008) 1.36
Detection and differentiation of Plasmodium species by polymerase chain reaction and colorimetric detection in blood samples of patients with suspected malaria. Diagn Microbiol Infect Dis (2004) 1.10
A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis. Sex Transm Infect (2008) 0.93
European Malaria Vaccine Initiative: portfolio and perspectives for the future. Hum Vaccin (2010) 0.87
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol (2005) 5.66
Evidence of human metapneumovirus in Australian children. Med J Aust (2002) 3.65
Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol (2006) 3.50
Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction. Pediatrics (2008) 2.37
Molecular assays for detection of human metapneumovirus. J Clin Microbiol (2003) 2.32
Real-time PCR assays for detection of bocavirus in human specimens. J Clin Microbiol (2006) 2.29
Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS One (2008) 2.23
A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples. J Mol Diagn (2004) 2.21
Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens. Pediatrics (2007) 2.13
Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology (2013) 2.13
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis (2012) 2.05
New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol (2005) 2.04
Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust (2009) 1.97
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother (2007) 1.90
Sequence variation in primer targets affects the accuracy of viral quantitative PCR. J Clin Virol (2005) 1.80
Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol (2009) 1.75
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J (2011) 1.72
Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn (2006) 1.70
A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust (2008) 1.60
Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis (2004) 1.53
A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One (2011) 1.47
A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay for the detection of a broad range of influenza A subtypes, including H5N1. Diagn Microbiol Infect Dis (2005) 1.44
Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Infect (2010) 1.43
Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Med Microbiol (2004) 1.43
Molecular diagnosis of medical viruses. Curr Issues Mol Biol (2007) 1.42
Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis (2009) 1.39
Impact of competitive inhibition and sequence variation upon the sensitivity of malaria PCR. J Clin Microbiol (2007) 1.37
Flinders Island spotted fever rickettsioses caused by "marmionii" strain of Rickettsia honei, Eastern Australia. Emerg Infect Dis (2007) 1.30
A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children. J Clin Virol (2007) 1.28
Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol (2009) 1.24
Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes. J Infect Dis (2004) 1.23
Sequence variation can affect the performance of minor groove binder TaqMan probes in viral diagnostic assays. J Clin Virol (2005) 1.21
Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis (2008) 1.21
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother (2010) 1.20
Human metapneumovirus, Australia, 2001-2004. Emerg Infect Dis (2006) 1.18
The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother (2012) 1.17
A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis (2008) 1.17
Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother (2010) 1.16
Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR. J Clin Microbiol (2002) 1.15
A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med (2014) 1.12
Detection and differentiation of Plasmodium species by polymerase chain reaction and colorimetric detection in blood samples of patients with suspected malaria. Diagn Microbiol Infect Dis (2004) 1.10
A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler. Diagn Microbiol Infect Dis (2002) 1.08
Detection of human bocavirus in respiratory, fecal, and blood samples by real-time PCR. J Med Virol (2009) 1.08
Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc (2007) 1.06
Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS One (2013) 1.05
Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J Infect Dis (2006) 1.04
Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J Clin Microbiol (2010) 1.03
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial. Pediatr Infect Dis J (2012) 1.02
Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae. Antimicrob Agents Chemother (2006) 1.01
Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol (2006) 1.00